Abstract
Phase 3 Clinical Trial Candidate Rilparencel Demonstrates Consistent Phenotypic Characteristics during Ex Vivo Culture Expansion Process
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have